MedPath

Efficacy of probiotics and/or intermittent fasting to improve prediabetes

Not Applicable
Conditions
prediabetes
type 2 diabetes
Diet and Nutrition - Obesity
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12616001050448
Lead Sponsor
niversity of Auckland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
560
Inclusion Criteria

Prediabetes defined by HbA1c 41-49 mmol/mol inclusive
BMI of 30-40 (or 27-40 if Asian Indian ethnicity)

Exclusion Criteria

Previous bariatric surgery, BMI >40kg/m2, on glucose lowering medications, conditions that might influence body weight regulation (eg: malabsorption, thyroid disorders, eating disorders, use of systemic steroids, excess alcohol intake (>21 units per week in men, >14 units per week in women), stable body weight in previous 6 months, planned major changes in physical activity during the study to an extent that might interfere with the study outcome, blood donation withthin past 2 months prior to the study (and at the endpoints), adults with a weight change of >3kg within 3 months prior to first baseline visit, psychiatric disease, pregnant women or lactating, or intending to become pregnant within the study duration, significant renal disease (GFR<30), congestive heart failure, unexplained syncope, recent myocardial infarction or stroke within 6 months, porphyria, thalassemia (or other blood disorders in which HbA1c is inaccurate for glycemia), splenectomy, participation in other clinical studies within the previous 6 months, not accepting of 5:2 intermittent fasting or probiotic supplementation. For the MRI studies, those with any implanted metal or electornic devices will not be able to take part.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in HbA1c from baseline[3 months and 1 year]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath